ASX
Firebrick Pharma Limited
FRE:ASX•Healthcare
Sensitive ASX Announcement
Firebrick Pharma's Phase 3 Trial of Nasodine Resumes
Published: 21/03/23, 08:42am (AEST)•3 pages